Efficacy of the CHADS2 Scoring System to Assess Left Atrial Thrombogenic Milieu Risk Before Cardioversion of Non-Valvular Atrial Fibrillation-Reference-Cited by-同舟云学术

Efficacy of the CHADS2 Scoring System to Assess Left Atrial Thrombogenic Milieu Risk Before Cardioversion of Non-Valvular Atrial Fibrillation

Published:2013-09 Issue:5 Volume:112 Page:678-683
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Yarmohammadi Hirad,Klosterman Tristan,Grewal Gaganpreet,Alraies M. Chadi,Varr Brandon C.,Lindsay Bruce,Zurick Andrew O.,Shrestha Kevin,Tang W.H. Wilson,Bhargava Mandeep,Klein Allan L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation;Gage;JAMA,2001

2. Chronic atrial fibrillation: incidence, prevalence, and prediction of stroke using the congestive heart failure, hypertension, age >75, diabetes mellitus, and prior stroke or transient ischemic attack (CHADS2) risk stratification scheme;Rietbrock;Am Heart J,2008

3. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

4. Cardiovascular imaging in the management of atrial fibrillation;Wazni;J Am Coll Cardiol,2006

5. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo;Fatkin;J Am Coll Cardiol,1994

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence, predictors and management of left atrial appendage thrombogenic milieu in atrial fibrillation with low thromboembolic risk;Thrombosis Journal;2023-03-30

2. Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter;ESC Heart Failure;2022-08-30

3. Serum heparanase levels and left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation;Herz;2021-08-05

4. IoT medical image detection and rivaroxaban prevent thrombosis in patients with atrial fibrillation;Microprocessors and Microsystems;2021-03

5. A novel risk score for predicting left atrial and left atrial appendage thrombogenic milieu in patients with non-valvular atrial fibrillation;Thrombosis Research;2020-08